Refine by
Genomics Articles & Analysis
466 news found
However, genome engineering is a slow, inefficient, and arduous process that limits microbial producers. The emerging Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) system has greatly improved the efficiency of genome editing and simplified multilocus genome editing steps. It has also enabled the rapid disruption of metabolic ...
It is the creator of the SOPHiA DDM™ Platform, which analyzes complex genomic and multimodal data and generates real-time, actionable insights for a broad global network of hospital, laboratory, and biopharma institutions. ...
Next-generation sequencing (NGS) has revolutionized the field of genomics by enabling researchers to generate vast amounts of sequence data in a single experiment. ...
For example, utilizing CRISPR/Cas9 and other genome-editing tools, scientists are exploring ways to correct mutations that lead to glaucoma. ...
By integrating data from multiple sources, including genomics and proteomics, their AI models can identify unexplored targets, potentially accelerating the development of novel therapeutics. ...
As the practice worked with SOPHiA GENETICS throughout the year, it experienced the benefits of utilizing the SOPHiA DDM™ Platform for its next generation sequencing (NGS) testing and today announced it will begin to validate the SOPHiA DDM™ RNAtarget Technology and the SOPHiA DDM™ for Comprehensive Genomic Profiling (CGP) application. “In our time using ...
Genomenon’s Mastermind® Genomic Intelligence Platform provides comprehensive curated evidence for genomic data, as well an indexed content from more than 10 million full-text articles. ...
H5N1 is a subtype of influenza A virus and belongs to the genus Alpha influenza virus in the family Orthomyxoviridae. The genome of this RNA virus is segmented and consists of eight negative-sense single-stranded RNAs, abbreviated as PB2, PB1, PA, HA, NP, NA, MP, and NS. ...
Influenza A viruses are members of the Orthomyxoviridae family with a unique genome consisting of eight single-stranded negative-sense RNA fragments. ...
In this piece, we talked to the two presenters of the poster “The Validation of a Homologous Recombination Deficiency Assay into Clinical Practice within the NHS”, Elizabeth Ratsma, Pre-Registration Clinical Scientist – Cancer Genomics and Charlotte Flanagan, PhD, Innovation Lead, from The Royal Marsden NHS Foundation Trust. ...
A Centers for Disease Control and Prevention (CDC) report published on October 3, 2024, linked Burkholderia multivorans infections to ice machines in multiple healthcare facilities in the western United States. This post summarizes key findings, implications, and recommended practices for healthcare providers to ensure patient ...
The SOPHiA GENETICS study used cutting-edge multimodal machine learning models to analyze clinical, biological, genomic, and imaging data, pinpointing patient subgroups who are most likely to benefit from the combination treatment. ...
The solution combines the sophisticated analytics, state-of-the-art algorithms, and decentralized, cloud-based offerings of the SOPHiA DDM™ Platform, with the scientific and clinical expertise of MSK in cancer genomics to provide a best-in-class liquid biopsy solution. By increasing availability of MSK-ACCESS® powered with SOPHiA DDM™, SOPHiA GENETICS and ...
This non-invasive testing allows for cancer genomic profiling and disease monitoring. It reveals critical insights in many cases where genomic testing of tumor tissue may not be feasible due to insufficient tissue material, low quality of the obtained tissue, or the invasiveness of the procedure. ...
SOPHiA GENETICS provides a technology-agnostic cloud-native platform for the computing, standardization and analysis of genomic data, allowing inputs from any leading NGS technology. The decentralized SOPHiA DDM™ Platform breaks barriers inherent to the traditional lab approach, allowing for global reach into major hospitals and academic centers. ...
Data computed daily by the Platform has surged over the years with over 1.8 million genomic profiles being analyzed on the platform, at a rate of almost 30,000 analyses per month. ...
CD Genomics, a pioneering leader in genomic solutions, is proud to announce its cutting-edge whole genome sequencing (WGS) services. ...
CD Genomics, a leading provider of genomic research solutions, today announced the launch of its cutting-edge Nanopore sequencing services, marking a significant advancement in DNA and RNA analysis capabilities. ...
Adenoviruses (members of the family Adenoviridae) are medium-sized (90-100 nm), nonenveloped viruses with icosahedral nucleocapsids containing a double-stranded DNA genome. The name derives from the first isolation of an adenovirus from human adenoids in 1953. ...
Hazard Ratio of 9.69 vs. 2.13) In late 2023, Tempus formed a strategic collaboration with Personalis, Inc., a leader in advanced genomics for precision oncology, to co-commercialize NeXT Personal® Dx, an ultra-sensitive, tumor-informed MRD and monitoring test based on whole genome sequencing offered by Personalis. ...
ByTempus